Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-smal...
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
About this item
Full title
Author / Creator
Reck, Martin, Dr , Kaiser, Rolf, MD , Mellemgaard, Anders, MD , Douillard, Jean-Yves, Prof , Orlov, Sergey, Prof , Krzakowski, Maciej, Prof , von Pawel, Joachim, MD , Gottfried, Maya, MD , Bondarenko, Igor, Prof , Liao, Meilin, Prof , Gann, Claudia-Nanette, MD , Barrueco, José, PhD , Gaschler-Markefski, Birgit, PhD , Novello, Silvia, Prof , for the LUME-Lung 1 Study Group and LUME-Lung 1 Study Group
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background The phase 3 LUME-Lung 1 study assessed the efficacy and safety of docetaxel plus nintedanib as second-line therapy for non-small-cell lung cancer (NSCLC). Methods Patients from 211 centres in 27 countries with stage IIIB/IV recurrent NSCLC progressing after first-line chemotherapy, stratified by ECOG performance status, previous...
Alternative Titles
Full title
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
Authors, Artists and Contributors
Author / Creator
Kaiser, Rolf, MD
Mellemgaard, Anders, MD
Douillard, Jean-Yves, Prof
Orlov, Sergey, Prof
Krzakowski, Maciej, Prof
von Pawel, Joachim, MD
Gottfried, Maya, MD
Bondarenko, Igor, Prof
Liao, Meilin, Prof
Gann, Claudia-Nanette, MD
Barrueco, José, PhD
Gaschler-Markefski, Birgit, PhD
Novello, Silvia, Prof
for the LUME-Lung 1 Study Group
LUME-Lung 1 Study Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1751228412
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751228412
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(13)70586-2
